DE602008005643D1 - Parathormon-formulierungen und ihre anwendungen - Google Patents
Parathormon-formulierungen und ihre anwendungenInfo
- Publication number
- DE602008005643D1 DE602008005643D1 DE602008005643T DE602008005643T DE602008005643D1 DE 602008005643 D1 DE602008005643 D1 DE 602008005643D1 DE 602008005643 T DE602008005643 T DE 602008005643T DE 602008005643 T DE602008005643 T DE 602008005643T DE 602008005643 D1 DE602008005643 D1 DE 602008005643D1
- Authority
- DE
- Germany
- Prior art keywords
- pth
- formulations
- parathormone
- applications
- ionic surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 4
- 239000002736 nonionic surfactant Substances 0.000 abstract 3
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99606107P | 2007-10-26 | 2007-10-26 | |
| EP07021017A EP2052736A1 (de) | 2007-10-26 | 2007-10-26 | Parathyroidhormon-Formulierungen und ihre Verwendungen |
| PCT/EP2008/009069 WO2009053106A1 (en) | 2007-10-26 | 2008-10-27 | Parathyroid hormone formulations and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602008005643D1 true DE602008005643D1 (de) | 2011-04-28 |
Family
ID=39146901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602008005643T Active DE602008005643D1 (de) | 2007-10-26 | 2008-10-27 | Parathormon-formulierungen und ihre anwendungen |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP2052736A1 (de) |
| AT (1) | ATE501725T1 (de) |
| CY (1) | CY1112106T1 (de) |
| DE (1) | DE602008005643D1 (de) |
| DK (1) | DK2219665T3 (de) |
| ES (1) | ES2363272T3 (de) |
| HK (1) | HK1146465A1 (de) |
| HR (1) | HRP20110444T1 (de) |
| MX (1) | MX2010004388A (de) |
| PL (1) | PL2219665T3 (de) |
| PT (1) | PT2219665E (de) |
| RU (1) | RU2467762C2 (de) |
| SI (1) | SI2219665T1 (de) |
| WO (1) | WO2009053106A1 (de) |
| ZA (1) | ZA201002812B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013012349A (es) * | 2011-04-22 | 2014-07-09 | Radius Health Inc | Metodo para suministro de farmaco para pth, pthrp y peptidos relacionados. |
| EP2709645B1 (de) * | 2011-05-18 | 2023-08-09 | Eumederis Pharmaceuticals, Inc. | Verbesserte peptidarzneimittel |
| WO2013082427A1 (en) | 2011-11-30 | 2013-06-06 | 3M Innovative Properties Company | Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same |
| RU2015108756A (ru) * | 2012-08-13 | 2016-09-27 | Конинклейке Филипс Н.В. | Применение антиоксидантов в способах и средствах для детектирования молекул-мишений в пробе крови |
| HUE061499T2 (hu) | 2014-03-28 | 2023-07-28 | Univ Duke | Mellrák kezelése szelektív ösztrogénreceptor-módosítók alkalmazásával |
| CA2984200C (en) | 2015-04-29 | 2024-03-19 | Radius Pharmaceuticals, Inc. | Combinations of rad1901 and a cdk 4/6 inhibitor for treating cancer |
| GB201602880D0 (en) | 2016-02-18 | 2016-04-06 | Ge Healthcare Uk Ltd | Method and composition for biomolecule stabilization |
| MA45809B1 (fr) | 2016-03-01 | 2024-12-31 | Ascendis Pharma Bone Diseases A/S | Promédicaments de pth |
| EP3518961B1 (de) | 2016-09-29 | 2023-02-22 | Ascendis Pharma Bone Diseases A/S | Pth-verbindungen mit niedrigem spitze-zu-tiefpunkt-verhältnis |
| MX2019003181A (es) | 2016-09-29 | 2019-08-05 | Ascendis Pharma Bone Diseases As | Regimen de dosificacion para un compuesto de hormona paratiroidea (pth) de liberacion controlada. |
| CA3047411A1 (en) | 2017-01-05 | 2018-07-12 | Radius Pharmaceuticals, Inc. | Polymorphic forms of rad1901-2hcl |
| CN110996988A (zh) * | 2017-09-22 | 2020-04-10 | 旭化成制药株式会社 | 稳定性优异的含有特立帕肽的液态药物组合物 |
| AU2019297421B2 (en) | 2018-07-04 | 2024-08-29 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD 1901-2HCL |
| CA3107105A1 (en) * | 2018-07-30 | 2020-02-06 | Shire-Nps Pharmaceuticals, Inc. | Formulations for improved stability of recombinant human parathyroid hormone |
| AU2020221491B2 (en) * | 2019-02-11 | 2025-02-27 | Ascendis Pharma Bone Diseases A/S | Liquid pharmaceutical formulations of PTH conjugates |
| CN112439054B (zh) * | 2019-08-28 | 2023-05-16 | 深圳翰宇药业股份有限公司 | 一种特立帕肽缓释凝胶注射液及其制备方法 |
| WO2021195877A1 (en) * | 2020-03-30 | 2021-10-07 | Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. | Formulations of human parathyroid hormone (pth) and methods for producing same |
| CN113101275A (zh) * | 2021-05-27 | 2021-07-13 | 海南通用康力制药有限公司 | 注射用棓丙酯冻干粉针剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69429603T2 (de) * | 1993-09-22 | 2002-08-14 | Hisamitsu Pharmaceutical Co., Inc. | Iontophoresematrix |
| ZA966075B (en) * | 1995-07-27 | 1998-01-19 | Genentech Inc | Protein formulation. |
| EP1598074B1 (de) * | 2003-02-28 | 2019-01-02 | Chugai Seiyaku Kabushiki Kaisha | Proteinhaltige stabilisierte vorrichtung |
| JP5388415B2 (ja) * | 2003-11-13 | 2014-01-15 | アルザ・コーポレーシヨン | 経皮送達のための組成物及び装置 |
| WO2007044375A2 (en) * | 2005-10-06 | 2007-04-19 | Nastech Pharmaceutical Company Inc. | Pth formulations and methods of use |
| EP1931374A2 (de) * | 2005-10-06 | 2008-06-18 | Nastech Pharmaceutical Company Inc. | Pth-formulierungen und anwendungsverfahren |
| US8093207B2 (en) * | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
-
2007
- 2007-10-26 EP EP07021017A patent/EP2052736A1/de not_active Withdrawn
-
2008
- 2008-10-27 DE DE602008005643T patent/DE602008005643D1/de active Active
- 2008-10-27 DK DK08842081.5T patent/DK2219665T3/da active
- 2008-10-27 RU RU2010121165/15A patent/RU2467762C2/ru not_active IP Right Cessation
- 2008-10-27 PT PT08842081T patent/PT2219665E/pt unknown
- 2008-10-27 WO PCT/EP2008/009069 patent/WO2009053106A1/en active Application Filing
- 2008-10-27 ES ES08842081T patent/ES2363272T3/es active Active
- 2008-10-27 PL PL08842081T patent/PL2219665T3/pl unknown
- 2008-10-27 AT AT08842081T patent/ATE501725T1/de active
- 2008-10-27 EP EP08842081A patent/EP2219665B1/de active Active
- 2008-10-27 MX MX2010004388A patent/MX2010004388A/es active IP Right Grant
- 2008-10-27 SI SI200830278T patent/SI2219665T1/sl unknown
-
2010
- 2010-04-21 ZA ZA2010/02812A patent/ZA201002812B/en unknown
-
2011
- 2011-01-14 HK HK11100351.0A patent/HK1146465A1/xx not_active IP Right Cessation
- 2011-06-14 HR HR20110444T patent/HRP20110444T1/hr unknown
- 2011-06-16 CY CY20111100578T patent/CY1112106T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2467762C2 (ru) | 2012-11-27 |
| EP2052736A1 (de) | 2009-04-29 |
| SI2219665T1 (sl) | 2011-09-30 |
| CY1112106T1 (el) | 2015-11-04 |
| EP2219665A1 (de) | 2010-08-25 |
| DK2219665T3 (da) | 2011-06-27 |
| MX2010004388A (es) | 2010-08-10 |
| PL2219665T3 (pl) | 2011-11-30 |
| WO2009053106A1 (en) | 2009-04-30 |
| PT2219665E (pt) | 2011-06-29 |
| ATE501725T1 (de) | 2011-04-15 |
| RU2010121165A (ru) | 2011-12-10 |
| HRP20110444T1 (hr) | 2011-08-31 |
| EP2219665B1 (de) | 2011-03-16 |
| ZA201002812B (en) | 2011-12-28 |
| ES2363272T3 (es) | 2011-07-28 |
| HK1146465A1 (en) | 2011-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602008005643D1 (de) | Parathormon-formulierungen und ihre anwendungen | |
| CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
| CY1118360T1 (el) | Παρατεταμενης διαρκειας τοπικη αναισθητικη συνθεση η οποια περιεχει saib | |
| CO6311084A2 (es) | Combinaciones de compuestos activos que tienen propiedades insecticidas y acaricidas | |
| BR112015023391A8 (pt) | formulações de conjugados anticorpo-droga anti-egfr | |
| WO2011049958A3 (en) | Modulation of gel temperature of poloxamer-containing formulations | |
| CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
| MX2010010508A (es) | Composiciones de absorcion de sebo. | |
| PA8595901A1 (es) | "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos | |
| IL193074A0 (en) | Stable pharmaceutical formulations of montelukast sodium | |
| BRPI0516830A (pt) | composições de droga de liberação sustentada convenientemente implantáveis | |
| ECSP099413A (es) | COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO | |
| AR054581A1 (es) | Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion | |
| UA107582C2 (uk) | Таблетований препарат (4'-трифторметилфеніл)аміду (z)-2-ціано-гідроксибут-2-еноєвої кислоти з поліпшеною стійкістю | |
| DK1819227T3 (da) | Farmaceutisk formulering af decitabin | |
| AR035284A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
| CO6280573A2 (es) | Concentrados en suspension basados en aceite | |
| CY1108196T1 (el) | Αντιμικροβιακες φαρμακευτικες συνθεσεις χορηγουμενες απο το στομα | |
| CR9246A (es) | Formulaciones terapeuticas del factor de crecimiento de queratinocitos | |
| ECSP066912A (es) | Formulaciones de dispersiones sólidas de acetato de bazedoxifeno | |
| DK2344130T3 (da) | Farmaceutiske topiske sammensætninger | |
| UY29999A1 (es) | "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones" | |
| ATE531703T1 (de) | Benzochromenderivate | |
| NO20091517L (no) | Emulsjon | |
| EP2692723A8 (de) | Aryloxydihalopropenyl-ether-verbindung und verwendung davon |